References
- Grau C, Durante M, Georg D, et al. Particle therapy in Europe. Mol Oncol. 2020;14(7):1492–1499.
- Grau C, Baumann M, Weber DC. Optimizing clinical research and generating prospective high-quality data in particle therapy in Europe: introducing the European Particle Therapy Network (EPTN). Radiother Oncol. 2018;128(1):1–3.
- Lievens Y, Defourny N, Corral J, et al. ESTRO–HERO Consortium Collaborators. How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement. Lancet Oncol. 2020;21(1):e42–e54.
- Langendijk JA, Lambin P, De Ruysscher D, et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107(3):267–273.
- Karlsson M, Björk-Eriksson T, Mattsson O, et al. "Distributed proton radiation therapy"—a new concept for advanced competence support. Acta Oncol. 2006;45(8):1094–1101.
- Glimelius B, Ask A, Bjelkengren G, et al. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44(8):836–849.
- Langegård U, Ahlberg K, Fransson P, et al. Evaluation of quality of care in relation to health-related quality of life of patients diagnosed with brain tumor: a novel clinic for proton beam therapy. Support Care Cancer. 2019;27(7):2679–2691.
- Strategic Business Case for Particle Therapy in Denmark. Available from: https://www.sum.dk/Aktuelt/Nyheder/Kraeft/2013/Juli/SUM-offentliggoer-business-case-for-partikelterapi-til-kraeftpatienter.aspx
- Stick LB, Yu J, Maraldo MV, et al. Joint estimation of cardiac toxicity and recurrence risks after comprehensive nodal photon versus proton therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2017;97(4):754–761.
- Kankaanranta L, Seppälä T, Koivunoro H, et al. Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial. Int J Radiat Oncol Biol Phys. 2012;82(1):e67–e75.
- Lievens Y, Borras JM, Grau C. Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology. Acta Oncol. 2015;54(9):1275–1281.